月度归档： 2026 年 10 月

Why it matters: The financing brings Nouscom closer to testing whether vaccination can prevent cancer in people with inherited genetic mutations that substantially increase their lifetime risk. Early clinical data show encouraging signals, although the approach has yet to demonstrate a preventive benefit in a controlled trial.

Beauty subscription box service Ipsy has entered the growing wellness category. The company says Ipsy Wellness was built on recognizing that beauty and wellness have converged into one connected routine. 

Why it matters: The results are a setback for Osivax’s ambition to develop a standalone influenza vaccine targeting a conserved viral protein rather than the rapidly changing surface proteins targeted by conventional vaccines. However, the company believes its technology could still improve seasonal flu protection when combined with established vaccines.

Evotec: Joanna Holbrook takes over as CSO. Holbrook will join the management board on Nov. 1, succeeding Cord Dohrmann, who stepped down Sept. 30 by mutual agreement after 16 years in the role. Holbrook joins from Novo Nordisk, where she led research in cardiovascular, renal and hepatic disease as well as in vitro discovery platforms. At Evotec, she will oversee scientific strategy across its discovery and development services and technology platforms. Go deeper.

Galderma has signed an agreement to acquire all of ZO Skin Health for US$1.5 billion from its shareholders, including funds managed by Blackstone Tactical Opportunities and the Obagi family. 

Why it matters: Many people with ulcerative colitis do not reach or stay in remission on existing drugs. Microbiotica designed MB310, a once-daily capsule of eight live gut bacterial strains, to deliver lasting remission without suppressing the immune system.

The European Commission (EC) has approved Kimberly-Clark’s US$40 billion Kenvue acquisition following the beauty giant’s agreement to divest brands in the region. With the move, Kimberly-Clark has offered to offload all of its tampon and other feminine hygiene brands in the European Economic Area (EEA), effectively pulling out of the market in the region.

Why it matters: The sale gives cancer cell-therapy research that Lakefront was shutting down another chance to reach patients, with fresh financing and former Galapagos CEO Paul Stoffels among the executives returning to develop the technology they helped bring into Galapagos in 2022. Lakefront, which retains potential financial upside from the sale, is building a new pipeline focused on immunology and inflammation, led by a T-cell engager for autoimmune diseases.

Oral care brand Boka and functional soda company OliPop have partnered to release a limited-edition seasonal toothpaste. The product is inspired by the latter’s Pomegranate Sparkle soda and is said to deliver probiotic oral care “with a twist.”